Clinical Trial - Trial ChiCTR2100050335
Access comprehensive clinical trial information for ChiCTR2100050335 through Pure Global AI's free database. This Phase 4 trial is sponsored by Beijing Anding Hospital, Capital Medical University and is currently Recruiting. The study focuses on Depressive Disorder.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2100050335
Phase 4
Recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2100050335
View on Chinese Clinical Trial Registry
Untitled Trial
Esketamine reactivates the efficacy of antidepressants in the treatment of major depressive disorder: a double blind, randomized, controlled trial
Study Focus
Sponsor & Location
Beijing Anding Hospital, Capital Medical University
Self financed
China
Timeline & Enrollment
Phase 4
N/A
Sep 01, 2022
ICD-10 Classifications
Depressive conduct disorder
Recurrent depressive disorder, unspecified
Recurrent depressive disorder
Other recurrent depressive disorders
Recurrent depressive disorder, currently in remission
Data Source
Chinese Clinical Trial Registry
ChiCTR2100050335
Non-Device Trial